Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Clinical Utility of the Cylex ImmunKnow Assay in Hematopoietic Cell Transplantation

NCT00813501 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00813501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00813501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Clinical Utility of the Cylex ImmunKnow Assay in Hematopoietic Cell Transplantation
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Terminated
Start date
June 30, 2008
Completion date
June 30, 2010
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloproliferative disorders, graft versus host disease, infection, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes, myelodysplastic-myeloproliferative diseases, neuroblastoma, therapy-related toxicity